Written by : Jayati Dubey
September 4, 2023
The PRIP scheme is poised to support collaboration among pharmaceutical companies, research and innovation institutions, as well as start-up ventures, as it receives the green light with an allocation of INR 5,000 Cr from the Cabinet.
Launched by the government in August, the PRIP scheme is founded on the belief that the Indian pharmaceutical industry holds the potential to elevate its current 3.4% share of the global market to an impressive 5% by the year 2030.
The National Policy on Research and Development in Pharma-MedTech is a comprehensive strategy with a three-fold focus. Firstly, it aims to bolster the regulatory framework within the sector. Secondly, it endeavours to incentivise investment in innovation. Lastly, it seeks to cultivate an ecosystem conducive to innovation and research.
This translates into accelerating drug discovery and development, facilitating collaboration between industry and academia and streamlining existing policies to optimise research resources.
The PRIP scheme, with its generous allocation of INR 5,000 Cr, hones in on two primary components.
The first component involves the establishment of Centers of Excellence (CoEs) within existing institutions to fortify research infrastructure. The second component is geared towards promoting research in priority areas.
These priority areas include a wide spectrum of fields, such as developing new chemical and biological entities, precision medicines, medical devices, and solutions for combating antimicrobial resistance.
Currently, research and development activities in the pharmaceutical and medical technology sectors within public institutions are fragmented across various research departments and institutions. The policy's overarching goal is to promote coordination among industry and academia, enhancing overall efficiency and productivity.
India is home to the world's third-largest pharmaceutical industry by volume, with an approximately $50 billion valuation. While the Indian pharmaceutical sector has made significant strides in supplying affordable and high-quality generic drugs globally, it grapples with certain challenges.
These challenges include import dependence on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), a lag in developing biologics, biosimilars, and other emerging products, and a shortage of technological capacities.
The PRIP scheme is poised to stimulate collaboration among pharmaceutical companies, research institutions, and start-ups, extending its support to established pharmaceutical giants and burgeoning start-ups alike.
The holistic approach of the policy, coupled with the PRIP scheme, is anticipated to yield many benefits, such as a reduction in import dependence, an enhancement of overall healthcare indices, the creation of high-end research and innovation jobs, the promotion of collaboration, and the development of world-class research infrastructure.
As India's pharmaceutical industry aims to expand its global footprint, these initiatives are set to pave the way for transformative growth and innovation in the sector.
The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving senior digital health leaders. CHIME includes more than 5,000 members in 56 countries and two US territories and partners with over 150 healthcare IT businesses and professional services firms. CHIME enables its members and business partners to collaborate, exchange ideas, develop professionally and advocate the effective use of information management to improve the health and care throughout the communities they serve. CHIME's members are chief information officers (CIOs), chief medical information officers (CMIOs), chief nursing information officers (CNIOs), chief innovation officers (CIOs), chief digital officers (CDOs), and other senior healthcare leaders. The CHIME India Chapter became the first international chapter outside North America in 2016 and is now a community of over 70+ members in India. For more information, please visit www.chimecentral.org